GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (XPAR:VIRP) » Definitions » Institutional Ownership

Virbac (XPAR:VIRP) Institutional Ownership : 26.97% (As of May. 18, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Virbac Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Virbac's institutional ownership is 26.97%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Virbac's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Virbac's Float Percentage Of Total Shares Outstanding is 0.00%.


Virbac Institutional Ownership Historical Data

The historical data trend for Virbac's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Institutional Ownership Chart

Virbac Historical Data

The historical data trend for Virbac can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 29.83 30.01 29.98 28.65 29.03 28.66 28.17 27.24 26.95 26.97

Virbac Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Virbac (XPAR:VIRP) Business Description

Traded in Other Exchanges
Address
2065m LID, 1 ere avenue, Carros, FRA, 06516
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.

Virbac (XPAR:VIRP) Headlines

No Headlines